ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,343Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 393

$457K Total Retail Price of All Prescriptions

Rank: 79 out of 393

571 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
8% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 571 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 571 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 11,262 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

14% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
OMEPRAZOLE 707 661 1 6
LISINOPRIL 700 657 2 2
SIMVASTATIN 686 660 3 1
LEVOTHYROXINE SODIUM 664 618 4 3
HYDROCODONE-ACETAMINOPHEN 468 402 S3 5 5
FUROSEMIDE 329 300 6 8
AMLODIPINE BESYLATE 291 276 7 4
HYDROCHLOROTHIAZIDE 266 248 8 10
ATENOLOL 253 229 9 13
METFORMIN HCL 235 198 10 7
WARFARIN SODIUM 231 231 11 17
FLUTICASONE PROPIONATE 216 187 12 27
ZOLPIDEM TARTRATE 214 189 13 11
METOPROLOL TARTRATE 200 193 14 9
TAMSULOSIN HCL 182 182 15 25
FINASTERIDE 170 170 16 60
ALENDRONATE SODIUM 166 161 17 16
ALLOPURINOL 164 161 18 26
GABAPENTIN 153 138 19 15
TERAZOSIN HCL 151 140 20 38
LISINOPRIL-HYDROCHLOROTHIAZIDE 149 142 21 24
MELOXICAM 137 113 22 58
LOSARTAN POTASSIUM 131 123 23 12
RANITIDINE HCL 130 122 24 29
SERTRALINE HCL 116 109 25 28
GLIPIZIDE 110 110 26 32
POTASSIUM CHLORIDE 110 110 26 20
LOVASTATIN 109 109 28 14
VENTOLIN HFA 108 81 29 42
PREDNISONE 101 99 30 65
ATORVASTATIN CALCIUM 98 95 31 19
CARVEDILOL 95 91 32 21
MORPHINE SULFATE ER 89 26 S2 33 48
METOPROLOL SUCCINATE 84 79 34 22
FLUOXETINE HCL 83 74 35 37
BACLOFEN 78 77 36 79
CITALOPRAM HBR 76 72 37 23
DONEPEZIL HCL 75 75 38 34
AMITRIPTYLINE HCL 73 59 R 39 72
TRAMADOL HCL 69 69 40 30
PLAVIX 65 56 41 51
PAROXETINE HCL 64 64 42 61
ISOSORBIDE MONONITRATE ER 63 60 43 67
DIGOXIN 62 58 44 66
CLOPIDOGREL 62 61 44 33
CARISOPRODOL 61 49 R 46 45
NIFEDIPINE ER 61 56 46 91
CIPROFLOXACIN HCL 60 52 48 57
TIZANIDINE HCL 57 43 49 97
BENAZEPRIL HCL 56 56 50 40
TRIAMTERENE-HCTZ 55 55 51 49
LOSARTAN-HYDROCHLOROTHIAZIDE 52 52 52 31
OXYCODONE HCL 51 34 S2 53 36
TRIAMCINOLONE ACETONIDE 51 46 53 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.